ResMed Inc. (OTCMKTS:RSMDF) Files An 8-K Results of Operations and Financial Condition

Item2.02. Disclosure of Results of Operations and Financial
Condition.

On January23, 2017 we issued the press release attached as
Exhibit99.1. It is incorporated into this report by reference.
The press release describes the results of our operations for the
quarter ended December31, 2016.

Item8.01. Other Events.

On January23, 2017, we announced that our board of directors
declared a quarterly cash dividend of US $0.33 per share. The
dividend will have a record date of February9, 2017, payable on
March16, 2017. The dividend will be paid in U.S. currency to
holders of ResMeds common stock trading on the New York Stock
Exchange. Holders of Chess Depositary Instruments trading on the
Australian Securities Exchange will receive an equivalent amount
in Australian currency, based on the exchange rate on the record
date, and reflecting the 10:1 ratio between CDIs and NYSE shares.
The ex-dividend date will be February8, 2017 for common stock
holders and for CDI holders. ResMed has received a waiver from
the ASXs settlement operating rules, which will allow ResMed to
defer processing conversions between its common stock and CDI
registers from February7, 2017 through February9, 2017 inclusive.

Item9.01. Financial Statements and Exhibits.

We have authorized the person whose

ResMed Inc. (OTCMKTS:RSMDF) Recent Trading Information

ResMed Inc. (OTCMKTS:RSMDF) closed its last trading session 00.00 at 5.78 with 511 shares trading hands.